MIE Treatment for Two Weeks for Autism Spectrum Disorder

"MIE Treatment for Two Weeks received a score of 3, meaning that while it is still in Phase 3 trials, there is evidence to support both its efficacy and safety from multiple rounds of testing."

"Children that are between 5 to 12 years old may participate in this study."

"No, this study is not recruiting at the moment. Although the last update to the posting on clinicaltrials.gov was on September 22nd, 2022, the original post date was October 25th, 2017. There are other 311 studies which are presently enrolling patients."

"The aim of this study, as measured over an 8-week period starting from baseline, is to increase the number of children that achieve continence. Additionally, the investigators will secondary outcomes including caregiver strain and stress levels before and after treatment. The study also intends to measure changes in clinical global impression and parenting stress index scores."

"This trial is enrolling 138 children between the ages of 5 and 12 who have autism spectrum disorders. The following criteria must also be met: Males and females from 5 years of age to 12 years 11 months of age., Fewer than 60% of days are continent days or more than 1 day out of 7 is an incontinent day over the previous 7 days (a continent day is defined as a day with at least one continent bowel movement. An incontinent day is a day with an incontinent bowel movement regardless of whether a continent bowel movement also occurs)., Medication free or on stable medication (no changes"